神経成長因子の世界市場レポート 2025年

神経成長因子（NGF）の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.0％で16億3,000万米ドルに成長します。予測期間中の成長は、バイオ医薬品に対する需要の高まり、自己免疫性神経疾患の有病率の増加、神経炎症研究への注目の高まり、AI主導の創薬への投資の高まり、NGFベースの治療に対する消費者の需要の高まりに起因すると考えられます。予測期間中に予想される主な動向には、バイオテクノロジーの進歩、個別化医療戦略、革新的なドラッグデリバリーシステム、規制当局の承認、NGF抗体の開発などが含まれます。

神経疾患の有病率の上昇は、神経成長因子（NGF）市場の成長を促進すると予想されます。脳、脊髄、神経に影響を及ぼす神経疾患は、構造的、生化学的、電気的な異常によって引き起こされます。これらの障害の有病率の増加は、主に人口の高齢化と診断技術の進歩に起因しています。このような技術的向上は、神経障害の検出と報告を強化し、文書化された発生率の上昇につながっています。NGFは、神経細胞の維持、生存、再生に重要な役割を果たし、神経修復を促進し、疾患の進行を遅らせる可能性があるため、神経疾患への対応に不可欠です。例えば、2024年9月、オーストラリア保健福祉研究所は、オーストラリアにおける認知症患者が2023年の約41万1,100人から2058年には84万9,300人に増加すると予測しました。その結果、神経疾患の有病率の増加がNGF市場の拡大に寄与しています。

NGF市場の各社は、NGFモノクローナル抗体のような、NGFを阻害して効果的な疼痛緩和を提供するための先端製品の開発に注力しています。これらのモノクローナル抗体は、NGFを標的にして中和し、受容体との相互作用を遮断して神経の痛みや炎症を抑えるように設計された生物学的薬剤です。このアプローチは、痛みのシグナル伝達を調整し、神経細胞の生存をサポートするのに役立ちます。例えば、2022年2月、中国のバイオ医薬品会社Akeso, Inc.は、ヒト化IgG1モノクローナル抗体AK115を発表しました。この抗体は中国の国家医薬品監督管理局から承認を受け、がん関連痛を含む疼痛治療の臨床試験を開始しました。AK115は、NGFと受容体との相互作用を阻害することにより作用し、特にオピオイド抵抗性のがん患者に対して、長期的かつ非中毒性の疼痛緩和を提供し、QOLの向上を目指します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の神経成長因子 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の神経成長因子市場：成長率分析
• 世界の神経成長因子市場の実績：規模と成長、2019年～2024年
• 世界の神経成長因子市場の予測：規模と成長、2024年～2029年、2034年
• 世界の神経成長因子総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の神経成長因子市場：タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• アルファ神経成長因子（NGF）
• ベータ神経成長因子（NGF）
• ガンマ神経成長因子（NGF）
• その他のタイプ
• 世界の神経成長因子市場：エージェント別、実績と予測、2019年～2024年、2024年～2029年、2034年
• セネゲルミン
• その他のエージェント
• 世界の神経成長因子市場：適応症別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 神経変性疾患
• 脊髄損傷
• 眼疾患
• 上皮疾患
• 組織の治癒
• その他の適応症
• 世界の神経成長因子市場：流通チャネル別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 病院薬局
• オンライン薬局
• 小売薬局
• 世界の神経成長因子市場：エンドユーザー別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 病院
• ホームケア
• 専門クリニック
• その他のエンドユーザー
• 世界の神経成長因子市場、アルファ神経成長因子（α-NGF）の種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• 天然アルファNGF
• 組み換えアルファ-NGF
• 合成アルファ-NGF
• 調査用途向けアルファNGF
• 世界の神経成長因子市場、ベータ神経成長因子（B-NGF）の種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• ヒトベータNGF
• 動物由来ベータNGF
• 組み換えベータNGF
• 治療用ベータNGF
• 研究グレードのベータNGF
• 世界の神経成長因子市場、ガンマ神経成長因子（Y-NGF）の種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• 天然ガンマ-NGF
• 組み換えガンマNGF
• 合成ガンマ-NGF
• 神経変性調査のためのガンマ-NGF
• 世界の神経成長因子市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• ハイブリッドNGF分子
• NGF模倣物
• NGF遺伝子治療ベースの製品
• NGF注入バイオマテリアル

第7章 地域別・国別分析

• 世界の神経成長因子市場：地域別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 世界の神経成長因子市場：国別、実績と予測、2019年～2024年、2024年～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 神経成長因子市場：競合情勢
• 神経成長因子市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly & Company Overview, Products and Services, Strategy and Financial Analysis
  • Teva Pharmaceutical Industries Overview, Products and Services, Strategy and Financial Analysis
  • Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Genetech
• Dompe farmaceutici S.p.A.
• Promega Corporation
• Akeso Inc
• CUSABIO TECHNOLOGY LLC
• Staidson Beijing BioPharmaceuticals
• Biocare Medical LLC
• Beike Biotechnology
• Enzo Life Sciences Inc.
• Genexis Biotech Pvt. Ltd.
• Mimetogen Pharmaceuticals
• Alomone Labs
• MimeTech Srl
• Herantis Pharma
• Prospec-Tany Technogene Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 神経成長因子市場2029年：新たな機会を提供する国
• 神経成長因子市場2029年：新たな機会を提供するセグメント
• 神経成長因子市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Nerve growth factor (NGF) is a protein crucial for the growth, maintenance, and survival of nerve cells, particularly sensory and sympathetic neurons. It plays an essential role in the development of the nervous system and supports the regeneration of nerve cells following injury. NGF binds to specific receptors on nerve cells, activating pathways that aid in cell survival and differentiation.

The main types of nerve growth factors include alpha-nerve growth factor (NGF), beta-nerve growth factor (NGF), gamma-nerve growth factor (NGF), and others. Alpha-NGF is a protein vital for the growth and survival of neurons, as well as the development of the peripheral nervous system. It encompasses various agents, such as cenegermin, used for conditions such as neurodegenerative disorders, spinal cord injuries, eye disorders, epithelial diseases, tissue healing, and more. These treatments are distributed through multiple channels, including hospital pharmacies, online pharmacies, and retail pharmacies, and are utilized by a range of end users, including hospitals, home care settings, specialty clinics, and others.

The nerve growth factor market research report is one of a series of new reports from The Business Research Company that provides nerve growth factor market statistics, including the nerve growth factor industry global market size, regional shares, competitors with the nerve growth factor market share, detailed nerve growth factor market segments, market trends, and opportunities, and any further data you may need to thrive in the nerve growth factor industry. This nerve growth factor market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The nerve growth factor (NGF) market size has grown strongly in recent years. It will grow from $1.11 billion in 2024 to $1.20 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth observed during the historic period can be attributed to factors such as the rising incidence of traumatic brain injuries, the increasing prevalence of neurodegenerative diseases, greater investments in research and development, heightened awareness of nerve regeneration therapies, and a growing incidence of peripheral neuropathy.

The nerve growth factor (NGF) market size is expected to see strong growth in the next few years. It will grow to $1.63 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth during the forecast period can be attributed to the rising demand for biopharmaceuticals, an increase in the prevalence of autoimmune neurological disorders, a greater focus on neuroinflammation research, rising investments in AI-driven drug discovery, and growing consumer demand for NGF-based therapies. Key trends expected during the forecast period include advancements in biotechnology, personalized medicine strategies, innovative drug delivery systems, regulatory approvals, and the development of NGF antibodies.

The rising prevalence of neurological disorders is expected to drive the growth of the nerve growth factor (NGF) market. Neurological disorders, which impact the brain, spinal cord, and nerves, are caused by structural, biochemical, or electrical abnormalities. The growing prevalence of these disorders is mainly attributed to aging populations and advancements in diagnostic technologies. These technological improvements enhance the detection and reporting of neurological disorders, leading to a higher documented incidence. NGF plays a vital role in the maintenance, survival, and regeneration of neurons, making it essential for addressing neurological conditions by promoting neural repair and potentially slowing disease progression. For example, in September 2024, the Australian Institute of Health and Welfare projected that dementia cases in Australia would increase from approximately 411,100 in 2023 to 849,300 by 2058. As a result, the increasing prevalence of neurological disorders is contributing to the expansion of the NGF market.

Companies in the NGF market are focused on developing advanced products, such as NGF monoclonal antibodies, to inhibit NGF and provide effective pain relief. These monoclonal antibodies are biological drugs designed to target and neutralize NGF, blocking its interaction with receptors to reduce pain and inflammation in nerves. This approach helps regulate pain signaling and supports nerve cell survival. For instance, in February 2022, Akeso, Inc., a China-based biopharmaceutical company, introduced AK115, a humanized IgG1 monoclonal antibody. This antibody received approval from China's National Medical Products Administration to begin clinical trials for pain treatment, including cancer-related pain. AK115 works by blocking NGF's interaction with receptors, aiming to offer long-term, non-addictive pain relief, particularly for opioid-resistant cancer patients, thus enhancing their quality of life.

In June 2023, Dompe Farmaceutici, an Italy-based company known for developing the first recombinant human nerve growth factor, partnered with FarmaMondo Group to expand access to Oxervate (cenegermin). Through this partnership, FarmaMondo became the exclusive distributor of Oxervate in certain countries, making it more accessible for patients with neurotrophic keratitis outside the U.S., Canada, Italy, China, and Switzerland. FarmaMondo Group, a Switzerland-based pharmaceutical services provider, specializes in offering care services for rare diseases. This collaboration helps broaden access to NGF treatments for those in need.

Major players in the nerve growth factor market are Pfizer Inc., AstraZeneca Plc, Eli Lilly & Company, Teva Pharmaceutical Industries, Regeneron Pharmaceuticals Inc., Genetech, Dompe farmaceutici S.p.A., Promega Corporation, Akeso Inc, CUSABIO TECHNOLOGY LLC, Staidson Beijing BioPharmaceuticals, Biocare Medical LLC, Beike Biotechnology, Enzo Life Sciences Inc., Genexis Biotech Pvt. Ltd., Mimetogen Pharmaceuticals, Alomone Labs, MimeTech Srl, Herantis Pharma, Prospec-Tany Technogene Ltd., PainCeptor Pharma.

Asia-Pacific was the largest region in the nerve growth factor market in 2024. The regions covered in nerve growth factor report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the nerve growth factor market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The nerve growth factor market consists of sales of nerve growth factor protein supplements, nerve growth factor enriched cell culture media, nerve growth factor biomarker detection kits, and diagnostic assays. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nerve Growth Factor Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nerve growth factor market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nerve growth factor ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The nerve growth factor market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Alpha-Nerve Growth Factor (NGF); Beta-Nerve Growth Factor (NGF); Gamma-Nerve Growth Factor (NGF); Other Types
• 2) By Agents: Cenegermin; Other Agents
• 3) By Indication: Neurodegenerative Disorders; Spinal Cord Injuries; Eye Disorders; Epithelial Diseases; Tissue Healing; Other Indications
• 4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
• 5) By End-User: Hospitals; Homecare; Specialty Clinics; Other End-Users
• Subsegments:
• 1) By Alpha-Nerve Growth Factor (a-NGF): Natural Alpha-NGF; Recombinant Alpha-NGF; Synthetic Alpha-NGF; Alpha-NGF For Research Applications
• 2) By Beta-Nerve Growth Factor (B-NGF): Human Beta-NGF; Animal-Derived Beta-NGF; Recombinant Beta-NGF; Therapeutic Beta-NGF; Research-Grade Beta-NGF
• 3) By Gamma-Nerve Growth Factor (Y-NGF): Natural Gamma-NGF; Recombinant Gamma-NGF; Synthetic Gamma-NGF; Gamma-NGF for Neurodegenerative Research
• 4) Other Types: Hybrid NGF Molecules; NGF Mimetics; NGF Gene Therapy-Based Products; NGF-Infused Biomaterials
• Companies Mentioned: Pfizer Inc.; AstraZeneca Plc; Eli Lilly & Company; Teva Pharmaceutical Industries; Regeneron Pharmaceuticals Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Nerve Growth Factor Market Characteristics

3. Nerve Growth Factor Market Trends And Strategies

4. Nerve Growth Factor Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Nerve Growth Factor Growth Analysis And Strategic Analysis Framework

• 5.1. Global Nerve Growth Factor PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Nerve Growth Factor Market Growth Rate Analysis
• 5.4. Global Nerve Growth Factor Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Nerve Growth Factor Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Nerve Growth Factor Total Addressable Market (TAM)

6. Nerve Growth Factor Market Segmentation

• 6.1. Global Nerve Growth Factor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alpha-Nerve Growth Factor (NGF)
• Beta-Nerve Growth Factor (NGF)
• Gamma-Nerve Growth Factor (NGF)
• Other Types
• 6.2. Global Nerve Growth Factor Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cenegermin
• Other Agents
• 6.3. Global Nerve Growth Factor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Neurodegenerative Disorders
• Spinal Cord Injuries
• Eye Disorders
• Epithelial Diseases
• Tissue Healing
• Other Indications
• 6.4. Global Nerve Growth Factor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• 6.5. Global Nerve Growth Factor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End-Users
• 6.6. Global Nerve Growth Factor Market, Sub-Segmentation Of Alpha-Nerve Growth Factor (a-NGF), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Natural Alpha-NGF
• Recombinant Alpha-NGF
• Synthetic Alpha-NGF
• Alpha-NGF For Research Applications
• 6.7. Global Nerve Growth Factor Market, Sub-Segmentation Of Beta-Nerve Growth Factor (B-NGF), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Human Beta-NGF
• Animal-Derived Beta-NGF
• Recombinant Beta-NGF
• Therapeutic Beta-NGF
• Research-Grade Beta-NGF
• 6.8. Global Nerve Growth Factor Market, Sub-Segmentation Of Gamma-Nerve Growth Factor (Y-NGF), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Natural Gamma-NGF
• Recombinant Gamma-NGF
• Synthetic Gamma-NGF
• Gamma-NGF for Neurodegenerative Research
• 6.9. Global Nerve Growth Factor Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hybrid NGF Molecules
• NGF Mimetics
• NGF Gene Therapy-Based Products
• NGF-Infused Biomaterials

7. Nerve Growth Factor Market Regional And Country Analysis

• 7.1. Global Nerve Growth Factor Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Nerve Growth Factor Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Nerve Growth Factor Market

• 8.1. Asia-Pacific Nerve Growth Factor Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Nerve Growth Factor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Nerve Growth Factor Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Nerve Growth Factor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Nerve Growth Factor Market

• 9.1. China Nerve Growth Factor Market Overview
• 9.2. China Nerve Growth Factor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Nerve Growth Factor Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Nerve Growth Factor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Nerve Growth Factor Market

• 10.1. India Nerve Growth Factor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Nerve Growth Factor Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Nerve Growth Factor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Nerve Growth Factor Market

• 11.1. Japan Nerve Growth Factor Market Overview
• 11.2. Japan Nerve Growth Factor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Nerve Growth Factor Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Nerve Growth Factor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Nerve Growth Factor Market

• 12.1. Australia Nerve Growth Factor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Nerve Growth Factor Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Nerve Growth Factor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Nerve Growth Factor Market

• 13.1. Indonesia Nerve Growth Factor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Nerve Growth Factor Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Nerve Growth Factor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Nerve Growth Factor Market

• 14.1. South Korea Nerve Growth Factor Market Overview
• 14.2. South Korea Nerve Growth Factor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Nerve Growth Factor Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Nerve Growth Factor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Nerve Growth Factor Market

• 15.1. Western Europe Nerve Growth Factor Market Overview
• 15.2. Western Europe Nerve Growth Factor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Nerve Growth Factor Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Nerve Growth Factor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Nerve Growth Factor Market

• 16.1. UK Nerve Growth Factor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Nerve Growth Factor Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Nerve Growth Factor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Nerve Growth Factor Market

• 17.1. Germany Nerve Growth Factor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Nerve Growth Factor Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Nerve Growth Factor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Nerve Growth Factor Market

• 18.1. France Nerve Growth Factor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Nerve Growth Factor Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Nerve Growth Factor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Nerve Growth Factor Market

• 19.1. Italy Nerve Growth Factor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Nerve Growth Factor Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Nerve Growth Factor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Nerve Growth Factor Market

• 20.1. Spain Nerve Growth Factor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Nerve Growth Factor Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Nerve Growth Factor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Nerve Growth Factor Market

• 21.1. Eastern Europe Nerve Growth Factor Market Overview
• 21.2. Eastern Europe Nerve Growth Factor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Nerve Growth Factor Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Nerve Growth Factor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Nerve Growth Factor Market

• 22.1. Russia Nerve Growth Factor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Nerve Growth Factor Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Nerve Growth Factor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Nerve Growth Factor Market

• 23.1. North America Nerve Growth Factor Market Overview
• 23.2. North America Nerve Growth Factor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Nerve Growth Factor Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Nerve Growth Factor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Nerve Growth Factor Market

• 24.1. USA Nerve Growth Factor Market Overview
• 24.2. USA Nerve Growth Factor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Nerve Growth Factor Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Nerve Growth Factor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Nerve Growth Factor Market

• 25.1. Canada Nerve Growth Factor Market Overview
• 25.2. Canada Nerve Growth Factor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Nerve Growth Factor Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Nerve Growth Factor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Nerve Growth Factor Market

• 26.1. South America Nerve Growth Factor Market Overview
• 26.2. South America Nerve Growth Factor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Nerve Growth Factor Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Nerve Growth Factor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Nerve Growth Factor Market

• 27.1. Brazil Nerve Growth Factor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Nerve Growth Factor Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Nerve Growth Factor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Nerve Growth Factor Market

• 28.1. Middle East Nerve Growth Factor Market Overview
• 28.2. Middle East Nerve Growth Factor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Nerve Growth Factor Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Nerve Growth Factor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Nerve Growth Factor Market

• 29.1. Africa Nerve Growth Factor Market Overview
• 29.2. Africa Nerve Growth Factor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Nerve Growth Factor Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Nerve Growth Factor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Nerve Growth Factor Market Competitive Landscape And Company Profiles

• 30.1. Nerve Growth Factor Market Competitive Landscape
• 30.2. Nerve Growth Factor Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Eli Lilly & Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Teva Pharmaceutical Industries Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Nerve Growth Factor Market Other Major And Innovative Companies

• 31.1. Genetech
• 31.2. Dompe farmaceutici S.p.A.
• 31.3. Promega Corporation
• 31.4. Akeso Inc
• 31.5. CUSABIO TECHNOLOGY LLC
• 31.6. Staidson Beijing BioPharmaceuticals
• 31.7. Biocare Medical LLC
• 31.8. Beike Biotechnology
• 31.9. Enzo Life Sciences Inc.
• 31.10. Genexis Biotech Pvt. Ltd.
• 31.11. Mimetogen Pharmaceuticals
• 31.12. Alomone Labs
• 31.13. MimeTech Srl
• 31.14. Herantis Pharma
• 31.15. Prospec-Tany Technogene Ltd.

32. Global Nerve Growth Factor Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Nerve Growth Factor Market

34. Recent Developments In The Nerve Growth Factor Market

35. Nerve Growth Factor Market High Potential Countries, Segments and Strategies

• 35.1 Nerve Growth Factor Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Nerve Growth Factor Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Nerve Growth Factor Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer